These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6133894)

  • 1. Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action.
    Evans R
    J Immunol; 1983 Jun; 130(6):2511-3. PubMed ID: 6133894
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R; Kamdar SJ; Duffy TM; Krupke DM; Fuller JA; Dudley ME
    Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice.
    Watson SR; Miller TB; Redington TJ; Bullock WE
    J Immunol; 1983 Aug; 131(2):984-90. PubMed ID: 6134775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
    Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M
    Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characteristics of the effector cells induced by a combination therapy with cyclophosphamide and allogeneic lymphocytes.
    Sato S; Kimura S; Nakamura T; Akuzawa Y; Kodama K; Furukawa K; Kurashige S
    Cancer Invest; 1998; 16(1):18-25. PubMed ID: 9474247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Thy 1 thymocyte differentiation antigen in mouse mammary cancer cells in vitro].
    Kriukova IN; Litvinov SV
    Biull Eksp Biol Med; 1983 Aug; 96(8):81-4. PubMed ID: 6411148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide.
    Nomi S; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1984 Oct; 73(4):943-50. PubMed ID: 6237215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Giuliani F; Casazza AM; Di Marco A
    Biomedicine; 1973 Sep; 18(5):387-92. PubMed ID: 4752705
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of the immune response T-cell interactions.
    Dutton RW; Swain SL
    CRC Crit Rev Immunol; 1982 Feb; 3(3):209-61. PubMed ID: 6176399
    [No Abstract]   [Full Text] [Related]  

  • 13. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of class II-MHC antigens by tumor-associated and peritoneal macrophages: systemic induction during tumor growth and tumor rejection.
    Evans R; Blake SS; Saffer JD
    J Leukoc Biol; 1986 Nov; 40(5):499-509. PubMed ID: 3464672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response.
    Yu AS; Bernstein ID
    J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated isolation of unique Qa2+ Ia+ clonally derived cell lines from Qa2- mice.
    Rosenson RS; Flaherty L; Levine H; Reinisch CL
    J Immunol; 1982 Jul; 129(1):382-7. PubMed ID: 6979571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanoluminescence: an assay for lymphocyte analysis in neoplasia.
    Orel VE; Alekseyev SB; Grinevich YA
    J Biolumin Chemilumin; 1992 Oct; 7(4):239-44. PubMed ID: 1442175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of naive T cells inside tumors leads to eradication of established tumors.
    Yu P; Lee Y; Liu W; Chin RK; Wang J; Wang Y; Schietinger A; Philip M; Schreiber H; Fu YX
    Nat Immunol; 2004 Feb; 5(2):141-9. PubMed ID: 14704792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes.
    Kagamu H; Shu S
    J Immunol; 1998 Apr; 160(7):3444-52. PubMed ID: 9531305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.